Ovipauz L Tablet 21

Ovipauz L Tablet interacts with the following medicines:

• Hormonal Medications: This tablet may interact with other hormonal treatments, altering their effectiveness.
• Anticoagulants: This tablet may increase the risk of bleeding when taken with blood thinners like warfarin.
• Antibiotics: The effect of this tablet may be reduced when coadministered with antibiotics such as rifampin. 
• Anticonvulsants: Contraceptive effectiveness may be reduced when this tablet is coadministered with anticonvulsants like barbiturates.

• There are no significant food interactions with this medication.

Ovipauz L Tablet interacts with the following conditions:

• Thromboembolic Disorders and Other Vascular Problems: This tablet may increase the risk of thromboembolic events, such as blood clots in the veins or arteries. Women with a history of these disorders should use this medication with extreme caution or avoid it altogether.
• Hepatic Neoplasia: This medication may aggravate hepatic neoplasia or liver tumors. Regular liver function monitoring is recommended for patients with a history of liver issues.
• Gallbladder Disease: This tablet may increase the risk of gallbladder disease, particularly in women with a pre-existing condition. Monitor for symptoms like severe abdominal pain or jaundice.
• Elevated Blood Pressure: This medication can elevate blood pressure, so it is not recommended for women with uncontrolled hypertension. Regular monitoring is crucial.
• Bleeding Irregularities: It may cause breakthrough bleeding or spotting, especially during the initial months of use. Persistent irregularities should be reported to a healthcare provider.
• Lipid Disorders: The tablet may impact lipid metabolism, potentially worsening existing lipid disorders. Routine lipid profile checks are advised.
• Liver Function: This tablet may impair liver function, so patients with liver issues should use it cautiously and under medical supervision.
• Fluid Retention: This medication may cause fluid retention, which can worsen conditions like heart failure or renal impairment. Monitor symptoms like swelling or weight gain.
• Emotional Disorders: It may exacerbate emotional disorders such as depression or anxiety. Patients with a history of mood disorders should discuss this with their doctor.
• Gastrointestinal Motility: Reduced gastrointestinal motility may affect the absorption of this tablet. Women with severe gastrointestinal conditions should consult a healthcare provider.

Take the recommended daily dose of Ovipauz L Tablet as instructed by your doctor. The dosage may vary depending on your condition and response to the medication. Avoid exceeding the prescribed dose without consulting your doctor.

Overdosing on Ovipauz L Tablet may result in side effects such as nausea and bleeding. If you suspect an overdose, contact your doctor immediately.

If you miss a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not double the dose to make up for a missed one.